Halobetasol and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Halobetasol and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: halobetasol topical
Brand name: Bryhali, Ultravate, Ultravate X Cream, Ultravate X Ointment, Lexette
Synonyms: Halobetasol topical
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Halobetasol-Signifor (Pasireotide Injection)
- Halobetasol-Signifor Injection
- Halobetasol-Signifor LAR
- Halobetasol-Signifor LAR Injection
- Halobetasol-Siklos
- Halobetasol-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Halobetasol and Tazarotene
- Signifor (Pasireotide Extended-Release Injection)-Halobetasol and tazarotene topical
- Signifor (Pasireotide Extended-Release Injection)-Halobetasol Cream
- Signifor (Pasireotide Extended-Release Injection)-Halobetasol Cream and Ointment
- Signifor (Pasireotide Extended-Release Injection)-Halobetasol Cream and Ointment with Lactic Acid Cream
- Signifor (Pasireotide Extended-Release Injection)-Halobetasol Foam